Skip to content

A Study on Pathyadi Kwatha Nasya and Pathyadi Kwatha Pana In The Management Of Ardhavbhedaka

A Randomized Comparative Clinical Study On Pathyadi Kwatha Nasya And Pathyadi Kwatha Pana In The Management Of Ardhavbhedaka With Special Reference To Migraine - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100106
Enrollment
30
Registered
2026-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G431- Migraine with aura

Interventions

None listed

Sponsors

Jammu Institute Of Ayurveda And Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either sex of age between 18 years to 60 years. 2.Patients with clinical features of Ardhavbhedaka i.e.Headache,Nausea ,Vomitting,Aura. 3.Patients with Chronicity of disease more than 6 months and less than 3 years. 4.Patients willing to participate and able to provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients who are suffering from Hypertension, Diabetes Mellitus and likewise other Chronic diseases. 2.Patients suffering from Cervical Spondolysis,Middle ear infections,Trigeminal Neuralgia and Refractive error. 3.Patients suffering from Fever,Sinusitis. 4.Patients suffering from Secondary Headaches caused by Meningitis,Tumour Encephalitis. 5.Patients with history of Head injury and Brain Infections.

Design outcomes

Primary

MeasureTime frame
Improvement in subjective parameters of Ardhavbhedaka Subjective:1.Severity of headache. 2.Frequency of Headache : Assessed in terms of Frequency in days 3.Duration of Headache : Assessed in terms of Hours/day 4.Nausea 5.Vomiting 6.Vertigo 7.Aura Timepoint: Assessment: Percentage relief in symptoms and signs after 30 days of treatment.

Secondary

MeasureTime frame
1.Overall Percentage Improvement Score 2.Patient-Reported Quality of Life ImprovementTimepoint: Assessment after the Drug Free follow up at 45th day.

Countries

India

Contacts

Public ContactDr Aditi Sharma

Jammu Institute Of Ayurveda And Research

Dr.nitinmahajan1608@gmail.com9419119123

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026